199 results on '"Dizeyi, Nishtman"'
Search Results
2. A non-invasive 25-Gene PLNM-Score urine test for detection of prostate cancer pelvic lymph node metastasis
3. An 18-Gene Algorithm urine test for predicting prostate cancer metastasis and castration- resistance
4. Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up
5. Experimental in vivo model to evaluate the impact of Cernitin™ on pain response on induced chronic bladder inflammation
6. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines
7. Impact of Cernitin™ on induced chronic prostatitis in animal model for understanding management of lower urinary tract symptoms
8. Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model
9. Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients
10. Sialic Acid as a Biomarker Studied in Breast Cancer Cell Lines In Vitro Using Fluorescent Molecularly Imprinted Polymers
11. Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients
12. A 23-Gene Classifier urine test for prostate cancer prognosis
13. A 23‐Gene Classifier urine test for prostate cancer prognosis
14. Discrimination between Breast Cancer Cells and White Blood Cells by Non-Invasive Measurements : Implications for a Novel In Vitro-Based Circulating Tumor Cell Model Using Digital Holographic Cytometry
15. The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer
16. Regional distribution of neuroendocrine cells in the urogenital duct system of the male rat
17. Discrimination between Breast Cancer Cells and White Blood Cells by Non-Invasive Measurements: Implications for a Novel In Vitro-Based Circulating Tumor Cell Model Using Digital Holographic Cytometry
18. Sialic acid as a biomarker studied in breast cancer cells using fluorescent molecularly imprinted polymers, MIPs
19. Malignant lesions in the ventral prostate of alloxan-induced diabetic rats
20. Multiple Cellular Mechanisms Related to Cyclin A1 in Prostate Cancer Invasion and Metastasis
21. Hormonal Regulation of β2-Adrenergic Receptor Level in Prostate Cancer
22. Galiellalactone is a Novel Therapeutic Candidate Against Hormone-Refractory Prostate Cancer Expressing Activated Stat3
23. The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer
24. The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia: An in vitro study
25. Cell-based evidence regarding the role of FSH in prostate cancer
26. Correction: Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer
27. Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell lines
28. Targeted suppression of AR-V7 using PIP5K1? inhibitor overcomes enzalutamide resistance in prostate cancer cells
29. Targeted suppression of AR-V7 using PIP5K1 alpha inhibitor overcomes enzalutamide resistance in prostate cancer cells
30. Different expression levels of glycans on leukemic cells-a novel screening method with molecularly imprinted polymers (MIP) targeting sialic acid.
31. Different expression levels of glycans on leukemic cells—a novel screening method with molecularly imprinted polymers (MIP) targeting sialic acid
32. Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions.
33. Abstract B15: Androgen receptor recruitment to c-Jun promoter region regulates chemosensitivity of prostate cancer cells to taxane therapy
34. Sialic Acid-Imprinted Fluorescent Core–Shell Particles for Selective Labeling of Cell Surface Glycans
35. Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions
36. Corrigendum to “Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model” [Eur. J. Pharm. Sci. 41 (2) (2010) 369–375]
37. Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
38. Expression and localization of serotonin receptors in human breast cancer
39. Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.
40. Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer.
41. Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
42. Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer
43. Abstract C226: Phosphorylation of ser63/73 in c-jun is required to respond to docetaxel treatment in prostate cancer cells.
44. Cyclin A1 Modulates the Expression of Vascular Endothelial Growth Factor and Promotes Hormone-Dependent Growth and Angiogenesis of Breast Cancer
45. Functional in vitro characterisation of the androgen receptor GGN polymorphism.
46. Androgen Receptor Enhances p27 Degradation in Prostate Cancer Cells through Rapid and Selective TORC2 Activation
47. Long-term testosterone stimulation induces hyperplasia in the guinea-pig prostate.
48. Regional distribution of neuroendocrine cells in the urogenital duct system of the male rat
49. OVEREXPRESSION OF PHOSPHORYLATED C-JUN IN PROSTATE CANCER CELLS INTERFERES WITH DOCETAXEL RESISTANT THERAPY IN IN VIVO MODEL
50. 1320: Increased Expression of RHOA in Prostates of Spontaneously Hypertensive Rats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.